立体超选择性动脉灌注化疗在乳腺癌降期保乳术中的价值
动脉灌注,,乳腺癌;立体超选择性动脉灌注化疗;保留乳房手术,1资料与方法,2结果,3讨论,【参考文献】
【摘要】 目的 评价术前立体超选择动脉灌注化疗在Ⅰ、Ⅱ期乳腺癌保留乳房手术(BCT)中的价值。方法 术前采用立体超选择动脉灌注丝裂霉素(MMC) 8~12mg/m2、表阿霉素(EADR) 60~80mg/m2和5-氟脲嘧啶(5-Fu)750~1000mg/m2,共治疗36例乳腺癌,其中Ⅰ期10例,Ⅱ期26例。化疗后再进行手术。结果 灌注化疗后CR+PR 32例,MR 3例,1例无明显变化,缓解率达89%。Ⅱ期患者中有22例肿瘤直径缩小到2cm以下,获得BCT手术机会。结论 术前立体超选择性动脉灌注化疗可使Ⅱ期乳腺癌降期获得BCT手术机会。【关键词】 乳腺癌;立体超选择性动脉灌注化疗;保留乳房手术
Importance of preoperational stereotactic superselective intraarterial chemotherapy in lowering stage for breast carcinoma conservative surgical treatment(BCT) of breast cancer
HE Jin-song,WANG Xian-ming,TONG Jian-meng,et al. The Center of Diagnosis and Treatment to Breast Disease,The Second Hospital of Shenzhen City,Shenzhen 518035,China
【Abstract】 Objective To evaluate the importance of preoperational stereotactic superselective intraarterial chemotherapy in breast carcinoma conservative surgical treatment(BCT) for phase Ⅰ、Ⅱ breast cancer.Methods To treat thirty-six cases of breast cancer patients(including phase Ⅰ 10 cases,phase Ⅱ 26 cases) by infusing MMC8~12mg/m2,EADR60~80mg/m2 ......
您现在查看是摘要页,全文长 9155 字符。